Literature DB >> 2478893

In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P.

C J Wiedermann1, F J Wiedermann, A Apperl, G Kieselbach, G Konwalinka, H Braunsteiner.   

Abstract

Polymorphonuclear leukocytes (PMNL) are a component of the inflammatory response to neurogenic mediators. Using the micropore filter approach, the authors studied the chemoattracting properties of tachykinins, including substance P (SP), neurokinin A (NKA) and neurokinin B (NKB), and that of calcitonin gene-related peptide (CGRP) for human PMNL in vitro and now show that SP in near nanomolar concentrations stimulates locomotion of human PMNL. Locomotion of PMNL is induced by SP, aminoterminal SP (1-9) and the SP receptor antagonist [D-pro2, D-trp7,9]-SP (DPDT) but not by carboxyterminal SP (3-11), NKA, NKB, or CGRP suggesting that the aminoterminal amino acids arginine and proline are essential residues of SP in activation of PMNL locomotion. In contrast, the migratory effect of SP on monocytes resides in the carboxyterminal SP amino acid sequence, which is in agreement with carboxyterminal, SP receptor-mediated chemotaxis of human monocytes previously shown by others. From the known structure-activity relationships for SP receptors it is concluded that induction of PMNL migration by SP does not involve neurokinin-1 (NK-1), NK-2 or NK-3 receptors. "Checkerboard" analysis reveals that PMNL locomotion by SP is not dependent on concentration gradients and thus represents chemokinesis, which is enhancement of speed and/or frequency of locomotion. One cannot exclude that this action of SP on PMNL is mediated by the aminoterminal sequence via yet unknown SP "receptors".(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478893     DOI: 10.1007/bf00168967

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

1.  Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha.

Authors:  I S Figari; N A Mori; M A Palladino
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

2.  Modulation of blood pressure by substance P: opposite effects of N- and C- terminal fragments on anesthetized rats.

Authors:  M E Hall; F B Miley; J M Stewart
Journal:  Life Sci       Date:  1987-05-11       Impact factor: 5.037

3.  Neuropeptides and the immune system. Substance P receptors in bronchus-associated lymphoid tissue of rat.

Authors:  C J Wiedermann; K Sertl; C B Pert
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

4.  Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence.

Authors:  Z Bar-Shavit; R Goldman; Y Stabinsky; P Gottlieb; M Fridkin; V I Teichberg; S Blumberg
Journal:  Biochem Biophys Res Commun       Date:  1980-06-30       Impact factor: 3.575

5.  Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil.

Authors:  W A Marasco; H J Showell; E L Becker
Journal:  Biochem Biophys Res Commun       Date:  1981-04-30       Impact factor: 3.575

Review 6.  Leukocyte chemotaxis.

Authors:  E Schiffmann
Journal:  Annu Rev Physiol       Date:  1982       Impact factor: 19.318

7.  Bombesin in human and guinea pig alveolar macrophages.

Authors:  C J Wiedermann; M E Goldman; J J Plutchok; K Sertl; M A Kaliner; A Johnston-Early; M H Cohen; M R Ruff; C B Pert
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

Review 8.  Rheumatoid arthritis. The role of neutrophil activation.

Authors:  G Weissmann; H Korchak
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

9.  Benzodiazepine receptor-mediated chemotaxis of human monocytes.

Authors:  M R Ruff; C B Pert; R J Weber; L M Wahl; S M Wahl; S M Paul
Journal:  Science       Date:  1985-09-20       Impact factor: 47.728

10.  Tachykinins: effects on motility and metabolism of rat polymorphonuclear leucocytes.

Authors:  M Roch-Arveiller; D Regoli; B Chanaud; M Lenoir; O Muntaner; S Stralzko; J P Giroud
Journal:  Pharmacology       Date:  1986       Impact factor: 2.547

View more
  7 in total

Review 1.  Recent aspects of gonadal hormone and neurotransmitter interactions with synovial and immune cells: implications in rheumatoid arthritis.

Authors:  M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Effect of substance P and somatostatin on migration of polymorphonuclear (PMN) cells in vitro.

Authors:  G Partsch; M Matucci-Cerinic
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

3.  Anchoring a cytoactive factor in a wound bed promotes healing.

Authors:  Sayani Chattopadhyay; Kathleen M Guthrie; Leandro Teixeira; Christopher J Murphy; Richard R Dubielzig; Jonathan F McAnulty; Ronald T Raines
Journal:  J Tissue Eng Regen Med       Date:  2014-03-27       Impact factor: 3.963

4.  Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes.

Authors:  Chang Jiang Guo; Jian Ping Lai; Hong Mei Luo; Steven D Douglas; Wen Zhe Ho
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

5.  Activation of human neutrophils by tachykinins: effect on formyl-methionyl-leucyl-phenylalanine- and platelet-activating factor-stimulated superoxide anion production and antibody-dependent cell-mediated cytotoxicity.

Authors:  A Wozniak; W H Betts; G McLennan; R Scicchitano
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

6.  Role of the tachykinin NK1 receptor in a murine model of cigarette smoke-induced pulmonary inflammation.

Authors:  Katelijne O De Swert; Ken R Bracke; Tine Demoor; Guy G Brusselle; Guy F Joos
Journal:  Respir Res       Date:  2009-05-15

7.  Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium.

Authors:  E W Greeno; P Mantyh; G M Vercellotti; C F Moldow
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.